Hospital mortality in hematogenous vertebral osteomyelitis

Objective. To analyze lethal outcomes in patients with hematogenous vertebral osteomyelitis. Material and Methods. Study design: retrospective analysis of medical records. A total of 209 medical records of inpatients who under- went treatment for hematogenous vertebral osteomyelitis in 2006–2017 w...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksandr Yu. Bazarov, Konstantin S. Sergeyev, Aleksey O. Faryon, Roman V. Paskov, Ilya A. Lebedev
Formato: article
Lenguaje:EN
RU
Publicado: Ministry of Health of Russian Federation, Federal State Budgetary Institution "Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan" 2021
Materias:
Acceso en línea:https://doaj.org/article/34cec8ffbcab4b8ea41fe69e091c7e24
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Objective. To analyze lethal outcomes in patients with hematogenous vertebral osteomyelitis. Material and Methods. Study design: retrospective analysis of medical records. A total of 209 medical records of inpatients who under- went treatment for hematogenous vertebral osteomyelitis in 2006–2017 were analyzed. Out of them 68 patients (32.5 %) were treated conservatively, and 141 (67.5 %) – surgically. The risk factors for lethal outcomes were studied for various methods of treatment, and a statistical analysis was performed. Results. Hospital mortality (n = 9) was 4.3 %. In patients who died in hospital, average time for diagnosis making was 4 times less (p = 0.092). The main factors affecting mortality were diabetes mellitus (p = 0.033), type C lesion according to the Pola classification (p = 0.014) and age over 70 years (p = 0.006). To assess the relationship between hospital mortality and the revealed differences be- tween the groups, a regression analysis was performed, which showed that factors associated with mortality were Pola type C.4 lesions (OR 9.73; 95 % CI 1.75–54.20), diabetes mellitus (OR 5.86; 95 % CI 1.14–30.15) and age over 70 years (OR 12.58; 95 % CI 2.50–63.34). The combination of these factors increased the likelihood of hospital mortality (p = 0.001). Sensitivity (77.8 %) and specificity (84.2 %) were calculated using the ROC curve. In the group with mortality, the comorbidity index (CCI) was significantly higher (≥4) than in the group without mortality (p = 0.002). With a CCI of 4 or more, the probability of hospital death increases significantly (OR 10.23; 95 % CI 2.06–50.82), p = 0.005. Long-term mortality was 4.3 % (n = 9), in 77.8 % of cases the cause was acute cardiovascular pathology, and no recurrence of vertebral osteomyelitis was detected. Conclusion. Hospital mortality was 4.3 %, and there was no mortality among patients treated conservatively. The main risk factors were diabetes mellitus, type C lesion according to Pola and age over 70 years. There was a significant mutual burdening of these factors (p = 0.001). With CCI ≥4, the probability of death is higher (p = 0.005).